000125288 001__ 125288
000125288 005__ 20240228145521.0
000125288 0247_ $$2doi$$a10.1128/JCM.01463-16
000125288 0247_ $$2pmid$$apmid:28330894
000125288 0247_ $$2pmc$$apmc:PMC5442522
000125288 0247_ $$2ISSN$$a0095-1137
000125288 0247_ $$2ISSN$$a1098-660X
000125288 037__ $$aDKFZ-2017-01426
000125288 041__ $$aeng
000125288 082__ $$a570
000125288 1001_ $$aLee, Justin S$$b0
000125288 245__ $$aTargeted Enrichment for Pathogen Detection and Characterization in Three Felid Specie
000125288 260__ $$aWashington, DC$$bSoc.$$c2017
000125288 3367_ $$2DRIVER$$aarticle
000125288 3367_ $$2DataCite$$aOutput Types/Journal article
000125288 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1525776027_10339
000125288 3367_ $$2BibTeX$$aARTICLE
000125288 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000125288 3367_ $$00$$2EndNote$$aJournal Article
000125288 520__ $$aTraditional diagnostic assays often lack sensitivity and can be difficult to multiplex across many pathogens. Next-generation sequencing (NGS) can overcome some of these problems but has limited application in the detection of low-copy-number pathogens in complex samples. Targeted genome capture (TGC) utilizes oligonucleotide probes to enrich specific nucleic acids in heterogeneous extracts and can therefore increase the proportion of NGS reads for low-abundance targets. While earlier studies have demonstrated the utility of this technology for detection of novel pathogens in human clinical samples, the capacity and practicality of TGC-NGS in a veterinary diagnostic setting have not yet been evaluated. Here we report the use of TGC-NGS assays for the detection and characterization of diverse feline pathogen taxa. We detected 31 pathogens comprising nine pathogen taxa in 28 felid samples analyzed. This included 20 pathogens detected via traditional PCR and 11 additional pathogens that had not been previously detected in the same samples. Most of the pathogens detected were sequenced at sufficient breadth and depth to confidently classify them at the species or subspecies level. Target nucleic acids were enriched from a low of 58-fold to 56 million-fold relative to host nucleic acids. Despite the promising performance of these assays, a number of pathogens detected by conventional PCR or serology were not isolated by TGC-NGS, suggesting that further validation is required before this technology can be used in lieu of quality-controlled standard assays. We conclude that TGC-NGS offers great potential as a broad multiplex pathogen characterization assay in veterinary diagnostic and research settings.
000125288 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000125288 588__ $$aDataset connected to CrossRef, PubMed,
000125288 7001_ $$aMackie, Ryan S$$b1
000125288 7001_ $$aHarrison, Thomas$$b2
000125288 7001_ $$aShariat, Basir$$b3
000125288 7001_ $$aKind, Trey$$b4
000125288 7001_ $$0P:(DE-He78)d62b83b4d50fc81a7b45d3a16a47ddf0$$aKehl, Timo$$b5$$udkfz
000125288 7001_ $$0P:(DE-He78)9c8a7dc019ff6a8d3da29f2069054a6f$$aLöchelt, Martin$$b6$$udkfz
000125288 7001_ $$aBoucher, Christina$$b7
000125288 7001_ $$00000-0001-9227-1622$$aVandeWoude, Sue$$b8
000125288 773__ $$0PERI:(DE-600)1498353-9$$a10.1128/JCM.01463-16$$gVol. 55, no. 6, p. 1658 - 1670$$n6$$p1658 - 1670$$tJournal of clinical microbiology$$v55$$x1098-660X$$y2017
000125288 909CO $$ooai:inrepo02.dkfz.de:125288$$pVDB
000125288 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d62b83b4d50fc81a7b45d3a16a47ddf0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000125288 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9c8a7dc019ff6a8d3da29f2069054a6f$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000125288 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000125288 9141_ $$y2017
000125288 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000125288 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000125288 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000125288 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN MICROBIOL : 2015
000125288 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000125288 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000125288 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000125288 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000125288 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000125288 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000125288 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000125288 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000125288 9201_ $$0I:(DE-He78)F020-20160331$$kF020$$lMolekulare Diagnostik Oncogener Infektionen$$x0
000125288 9201_ $$0I:(DE-He78)V155-20160331$$kV155$$lBiologische Sicherheit$$x1
000125288 980__ $$ajournal
000125288 980__ $$aVDB
000125288 980__ $$aI:(DE-He78)F020-20160331
000125288 980__ $$aI:(DE-He78)V155-20160331
000125288 980__ $$aUNRESTRICTED